o-desmethylindomethacin has been researched along with substance p (5-11), asp(5,6)-mephe(8)- in 1 studies
Studies (o-desmethylindomethacin) | Trials (o-desmethylindomethacin) | Recent Studies (post-2010) (o-desmethylindomethacin) | Studies (substance p (5-11), asp(5,6)-mephe(8)-) | Trials (substance p (5-11), asp(5,6)-mephe(8)-) | Recent Studies (post-2010) (substance p (5-11), asp(5,6)-mephe(8)-) |
---|---|---|---|---|---|
27 | 0 | 4 | 9 | 0 | 0 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kowalczyk, M; Lapo, I; Massi, M; Panocka, I; Sadowski, B; Swiderski, T | 1 |
1 other study(ies) available for o-desmethylindomethacin and substance p (5-11), asp(5,6)-mephe(8)-
Article | Year |
---|---|
Antidepressant-type effect of the NK3 tachykinin receptor agonist aminosenktide in mouse lines differing in endogenous opioid system activity.
Topics: Analgesia; Animals; Antidepressive Agents; Behavior, Animal; Cell Line; Dose-Response Relationship, Drug; Female; Indomethacin; Male; Mice; Naltrexone; Narcotics; Peptide Fragments; Receptors, Tachykinin; Substance P; Swimming | 2001 |